The fermentation-inhibition (FI) test for Mycoplasma pneumoniae was performed with two strains of M. pneumoniae, one susceptible to erythromycin and one highly resistant to erythromycin with cross-resistance to other macrolide antibiotics. Serum titers in children with M. pneumoniae pneumonia who received no antibiotic were similar with the two strains. Children with atypical pneumonia with a transient rise in the Fl titer with the susceptible strain proved to have received erythromycin at the time of the rise. They showed no rise in the Fl titer done with the erythromycin-resistant strain. (1) reported that the administration of antibiotics, especially erythromycin, elevated serum tetrazolium reduction-inhibiting titers. Smith and Herrmann (3) reported that there appeared to be no practical way whereby this antibiotic interference in the metabolic inhibition test could be eliminated.
Two methods of metabolic inhibition testing were devised for the measurement of serum antibody to M. pneumoniae. The tetrazolium reduction-inhibition test was reported by Jensen (K. E. Jensen, Bacteriol. Proc., p. 70-71, 1964) and Senterfit and Jensen (2). The fermentation-inhibition (FI) test devised by TaylorRobinson et al. (4) is especially useful in serodiagnostic and seroepidemiological studies of M. pneumoniae infections. However, Mogabgab (1) reported that the administration of antibiotics, especially erythromycin, elevated serum tetrazolium reduction-inhibiting titers. Smith and Herrmann (3) reported that there appeared to be no practical way whereby this antibiotic interference in the metabolic inhibition test could be eliminated.
We succeeded in making M. pneumoniae highly resistant to erythromycin in vitro (Y. Niitu et al., Antimicrob. Ag. Chemother., submitted for publication). Performance of the FI test with both the erythromycin-sensitive and -resistant strains of M. pneumoniae revealed the usefulness of the resistant strain in avoiding false results in sera from patients receiving certain antibiotics.
MATERIALS AND METHODS M. pneumoniae. The Mac strain, a prototype M. pneumoniae, was used as the erythromycin-sensitive strain. The Mac strain was rendered resistant to erythromycin. The minimal growth-inhibitory conmycin by serial subculture in broth media containing erythromycin. The minimum growth-inhibitory concentrations (MGIC) of antibiotics for these strains are shown in Table 1 . The two strains were propagated in broth medium, distributed into tubes, and kept at U -70 C. The two cultures contained 1 x 108 colonyforming units per ml.
Media. Broth medium for the Fl test consisted of seven parts of pleuropneumonia-like organism broth (Difco), two parts of unheated horse serum, and one part of 25% yeast extract. In addition, 1% glucose, 500 U of penicillin G per ml, 500 Ag of thallium acetate per ml, and 0.002% phenol red were included. The pH was adjusted to 7.8.
Fermentation-inhibition test. The details of the method which we used (4) have been described elsewhere (S. Hasegawa, Jap. J. Microbiol., in press). Sera were stored at -20 C and were heated at 56 C for 30 min before use. Serial twofold dilutions of serum were prepared, beginning with a dilution of 1:4. Broth containing M. pneumoniae was diluted 10-3 with broth medium for use as inoculum. Plates were sealed with cellophane tape, and the center of the tape over each cup was pierced with a needle to prevent nonspecific color change of the medium to slightly yellow. The titer was recorded when the control cup with only M. pneumoniae changed color to yellow (pH 6.7 or less). The highest initial serum dilution which prevented the distinct color change, when the pH of the medium was kept at 7.4 or over, was considered the antibody titer of the serum.
Source of sera. The FI antibody titer with the sensitive and resistant strains was determined on paired or serial sera from six children. These children were diagnosed as having M. pneumoniae pneumonia by isolation of M. pneumoniae or by a significant rise in complement-fixing antibody titer (or both) and were not treated with antibiotics. Erythromycin, josamycin, leucomycin, oleandomycin, spiramycin, lincomycin, tetracycline, and chloramphenicol were given orally to three to five subjects (adults and children, respectively) in a single dose of about 7 to 9 mg/kg of body weight (one-fourth of the daily dose). Serum was drawn before and 2, 4, 6, and Seven additional cases were receiving tetracycline and one case was receiving chloramphenicol on the day the in-between examination serum was drawn. None of these cases showed any significant rise in FI titer as determined with the sensitive strain.
Effect of oral administration of antibiotics on the FT titer of serum. All four individuals who received erythromycin, two of five who received leucomycin, and one of five who received oleandomycin showed a titer rise after drug administration when a susceptible strain was used in the FI test. However, no significant change in the titer was detected when the erythromycin-resistant strain was employed in the test (Fig. 2) . None of the other three and four individuals who received leucomycin and oleandomycin, respectively, and none of all three individuals who received josamycin, lincomycin, tetracycline, or chloramphenicol showed a significant change in titer, regardless of whether erythromycin-sensitive or -resistant strains were used in the test. DISCUSSION When the Fl test was performed with an erythromycin-sensitive strain of M. pneumoniae, the oral administratin of erythromycin caused a rise in serum titer. A similar rise was seen in some cases after oral administration of leucomycin or oleandomycin, but not with josamycin, spiramycin, and lincomycin. When the ervthromycin-resistant strain was used in the test, the false rise in titer was not observed. An antibiotic with a low MGIC is likely to cause such a false rise. The MGIC for the erythromycin-sensitive strain was the lowest for erythromycin and relatively low for leucomycin and oleandomycin among the antibiotics studied ( Table 1 ). The fact that josamycin, which has a relatively low MGIC, did not elevate FI titer after being orally administered suggests that its serum concentration did not reach a high level.
Tetracycline and chloramphenicol, to which both the erythromycin-sensitive and -resistant strains were sensitive, did not cause a false rise in the Fl titer after being orally administered. The reason may be that the MGIC of the two antibiotics were higher than those of erythromycin, as shown in Table 1 , and that their serum concentration did not exceed the MGIC enough to affect the Fl titer.
The test with the erythromycin-resistant strain can determine the true FI antibody titer in sera drawn from patients receiving erythromycin and certain other antibiotics or collected from a population for seroepidemiological study. The use of this strain may give true results in serodiagnosis of M. pneumoniae infections, avoiding the possible interference by the antibiotics. It is also assumed that the strain might avoid false results in the tetrazolium reduction-inhibition test in sera drawn after the antibiotics are given.
It may be concluded that the strain of M. pneumoniae resistant to erythromycin is suitable for the metabolic inhibition test for the measurement of antibody to M. pneumoniae. 
